Skip to main content
Explore URMC

Brain Cancer Research

Neuro-Oncology Team Making Progress Against Brain Tumors

Researchers and clinicians at Wilmot Cancer Institute strive to develop new therapies that can extend and improve patients’ lives. Neuro-Oncology research programs focus on:
  • Clinical trials for gliomas, the most common and deadly type of brain cancer
  • Tumor-associated epilepsy
  • Palliative care for those with glioblastoma
  • Alleviating neuropathy (nerve damage) caused by chemotherapy
  • Innovative therapies, such as tumor-treating field (TTfield) treatment), which uses alternating electric fields to interrupt cell division and keep tumors from growing
DennisWilmot patient Dennis DeVelder knows first-hand how important research in brain cancer is because it impacted the treatment he received. After being diagnosed with a low-grade brain tumor in 2008, he had two surgeries and radiation therapy, which were standard treatment for his type of tumor at the time. However, a study published in 2014 showed chemotherapy may reduce the chance of recurrence for people with his type of tumor, so he did a round of that, too.
“He only had that chemo because of the outcome of a study,” says Lacy Morgan-DeVelder, Dennis’s wife. “Also, knowing the type of radiation he had, we’ve gone to some of the support groups that they do here, and some of these guys who had radiation 20 years ago, they’re in a very different spot because their entire heads were radiated. Even the medicine so he wasn’t nauseous, all that came because of research. I think we appreciate that on a whole different level now.” Dennis was recognized at the 2016 Wilmot Warrior Walk along with 28 other cancer survivors. Read more about his story from the Batavia Daily News.

Adding Candles Turns Loss into Support for Brain Cancer Research

It’s usually a good thing to have experiences in common with your friends, but Lois Warlick-Jarvie and some of her friends realized they had something unfortunate in common: they had all known someone who had brain cancer. Rather than sit back, the group of about 20 supporters decided to do something against the disease that had taken their friends, family members and colleagues. They established a nonprofit called Adding Candles.  
“Our goal is to increase the years patients will live with brain cancer and the quality of those years by funding research – which will hopefully lead to a cure,” Warlick-Jarvie, president of Adding Candles, said in a press release.  
The group raised more than $50,000 at their first fundraiser in 2015, and in 2016, they raised an additional $75,000 to support the Neuro-Oncology research programs at Wilmot Cancer Institute. Nimish Mohile, M.D., associate professor in the division of Neuro-Oncology at Wilmot Cancer Institute and advising physician for Adding Candles, said the money raised from this event will have such an important impact.
“These funds will allow us the opportunity to bring our research to the next level with novel clinical trials — and maybe an eventual end to this devastating disease,” he said.
Like Adding Candles, you can have an impact on brain cancer research in Rochester. By giving, you can help ensure patients diagnosed with brain cancer in your community have access to the newest treatments that may help them live longer and more comfortably. Please give today.  

Make a Gift

Make your secure online gift today »